Your browser doesn't support javascript.
loading
Development of a microchip capillary electrophoresis method for determination of the purity and integrity of mRNA in lipid nanoparticle vaccines.
Raffaele, Jessica; Loughney, John W; Rustandi, Richard R.
Afiliación
  • Raffaele J; Analytical Research & Development, Merck & Co., Inc., West Point, PA, 19486, USA.
  • Loughney JW; Analytical Research & Development, Merck & Co., Inc., West Point, PA, 19486, USA.
  • Rustandi RR; Analytical Research & Development, Merck & Co., Inc., West Point, PA, 19486, USA.
Electrophoresis ; 43(9-10): 1101-1106, 2022 05.
Article en En | MEDLINE | ID: mdl-34806186
ABSTRACT
Messenger RNA (mRNA)-based vaccines are advantageous because they can be relatively quicker and more cost efficient to manufacture compared to other traditional vaccine products. Lipid nanoparticles have three common

purposes:

delivery, self-adjuvanting properties, and mRNA protection. Faster vaccine development requires an efficient and fast assay to monitor mRNA purity and integrity. Microchip CE is known to be a robust technology that is capable of rapid separation. Here, we describe the development and optimization of a purity and integrity assay for mRNA-based vaccines encapsulated in lipid nanoparticles using commercial microchip-based separation. The analytical parameters of the optimized assay were assessed and the method is a stability indicating assay.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Electroforesis por Microchip / Nanopartículas Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Electroforesis por Microchip / Nanopartículas Idioma: En Año: 2022 Tipo del documento: Article